Chapter: Alt-WL Platforms

DXtrade (Devexperts)

3.5

PARTIAL FIT

Munich-HQ, 800-engineer parent. Multi-asset depth (equities, futures, options) and native MiFID II reporting that no single-SKU MT5 WL replicates - at bespoke enterprise pricing.

scorecard

DXtrade (Devexperts)

Atlas score

3.5

Best for

  • CySEC brokers needing genuine multi-asset depth beyond FX/CFD
  • Prop firms running futures programmes with no credible MT5 substitute
  • Operators requiring institutional MiFID II reporting natively in the platform

Not for

  • Startup brokers on tight timelines or limited procurement bandwidth
  • Operators comparing vendors on published price sheets
  • CySEC startups prioritising client-facing UX over institutional depth

Pros

  • DXtrade XT covers equities, ETFs, futures, options, bonds, and crypto alongside FX/CFD - asset classes MetaTrader does not support.
  • Native MiFID II/MiFIR transaction reporting is built into the platform, not a bolt-on add-on.
  • DXcharts library is an actively maintained commercial product with no MetaTrader charting equivalent.
  • Devexa AI assistant is bundled free to licensees since 2024 - no comparable MT5 feature exists.
  • MAM/PAMM, IB management, and risk tools are included rather than requiring third-party add-ons.
  • 800+ Devexperts engineers provide bespoke feature delivery capacity that startup-focused vendors cannot match.

Cons

  • Pricing is bespoke and not published; setup reportedly $25k-$50k with multi-round RFP process required before any number surfaces.
  • UI is considered less retail-polished than cTrader, TradeLocker, or Match-Trader by most practitioners.
  • Three SKU variants (XT vs CFD vs FX) create evaluation confusion - operators frequently need a second call just to identify the right product.
  • No published Limassol office and fewer CySEC-specific case studies than Spotware or Match-Trade.
  • 7-day go-live claim applies only to off-the-shelf tier; CySEC-regulated deployments with MAM and MiFID II reporting will take substantially longer.

Pricing teardown

Setup fee
~$25,000-$50,000 (unverified)

Bespoke enterprise pricing; setup range from market research, not confirmed against current vendor quotes. Three licensing structures (off-the-shelf, enterprise, source-code) selected at scoping.

Editorial commentary

Who They Are

Devexperts is a financial software company founded in 2002, headquartered in Munich, Germany, with sales offices in Cyprus, the UK, Singapore, and the US. The DXtrade product line emerged around 2017 as a direct answer to the MetaTrader duopoly, and has since split into two distinct variants: DXtrade CFD (aimed at FX/CFD brokers) and DXtrade XT (a fuller multi-asset platform covering equities, options, and futures alongside spot FX). Both run as hosted SaaS with web, iOS, and Android clients - there is no native desktop client by design.

Within the alt-WL category, DXtrade occupies the upper-middle tier: it is not the cheapest or fastest to deploy, but it has credible institutional depth that most startup-focused competitors cannot match. Its primary appeal to CySEC operators is the combination of multi-asset coverage, MiFID II/MiFIR-ready reporting, and a parent company with 800+ engineers capable of bespoke feature delivery. The 2022 MetaQuotes WL freeze and subsequent 2025 MT5 main-label price increase created the demand environment DXtrade was positioned to capitalize on.

What You Actually Get vs MetaTrader

DXtrade’s concrete advantages over MT4/MT5 are most visible at the multi-asset depth end of the spectrum. DXtrade XT supports equities, ETFs, futures, options, mutual funds, bonds, and crypto alongside FX/CFD - asset classes that MetaTrader handles poorly or not at all. For prop firms running futures programmes (FTMO and FPFX Tech, according to vendor materials), there is currently no credible MT5-based substitute for this capability.

On the charting side, DXtrade deploys its own DXcharts library, which is also licensed as a standalone product. Unlike MetaTrader’s aging charting stack, DXcharts is maintained as a live commercial product with active development. The embedded Devexa AI assistant (available free to licensees since 2024) has no MetaTrader equivalent. Back-office functions - MAM/PAMM, IB management, risk tools - are bundled rather than requiring third-party add-ons.

Where MetaTrader retains a clear advantage: the MT4/MT5 retail trader recognition and EA ecosystem remain unmatched. DXtrade’s trader-side brand recognition is weak outside prop-firm circles. The multiple SKUs (XT vs CFD vs FX) also create evaluation friction that a single MetaTrader installation does not.

For brokers whose client base is already EA-dependent, DXtrade is a complement or a parallel offering, not a drop-in replacement.

Pricing Reality

DXtrade pricing is bespoke and not published. Setup fees are reportedly in the $25,000-$50,000 range for enterprise engagements, based on market research (unverified against current vendor quotes). The licensing structure spans three tiers: off-the-shelf (aimed at startups), enterprise (custom feature scope), and a source-code license that allows deep proprietary modification.

The 7-day go-live claim applies to the off-the-shelf tier; enterprise deployments will take considerably longer. Feature additions are priced against the bandwidth of Devexperts’ engineering pool, which means costs scale non-linearly with scope. Brokers should expect a full RFP process and at least two rounds of commercial negotiation before a number is on the table.

There is no publicly disclosed monthly recurring fee. Operators should budget for an annual license structure and factor in per-feature development costs if the base package requires customization - which, for most CySEC brokers doing MiFID II reporting and MAM, it will.

Cyprus Jurisdictional Fit

Devexperts operates a Cyprus sales presence and confirms regular attendance at iFX EXPO Cyprus (including as a speaker on prop-firm and multi-asset trends). The platform’s MiFID II/MiFIR transaction reporting is native to the product, not a bolt-on - relevant for any CySEC-licensed broker subject to transaction reporting obligations.

Named CySEC-connected customers in publicly available materials include ATFX (via Centroid integration, per company disclosure). Other referenced customers (FTMO, BrightFunded) are prop firms operating outside the CySEC licensing framework. The Cyprus sales office indicates active go-to-market investment in the region, but operators should not assume Limassol-cluster peer references are available - those require direct vendor conversation.

For operators prioritising jurisdictional fit, the institutional depth and MiFID II coverage are the relevant signals. The lack of a published Limassol office and lighter CySEC-specific case study disclosure compared with Spotware or Match-Trade is a meaningful gap.

Partner Program Reality

DXtrade operates direct B2B sales only. There is no public broker affiliate or IB reseller program. All commercial relationships are initiated through the Devexperts sales team. For a CySEC broker evaluating the platform, this means the buying process starts with cold or warm outreach to the vendor rather than through any structured partner network - a BD-friction signal that adds calendar time to any evaluation compared with vendors offering self-serve pricing or public reseller tiers.

Where This Vendor Breaks Down

The opaque pricing model is the single biggest operational friction point for brokers doing competitive evaluation. Every quote is bespoke, which slows comparative analysis and can extend procurement timelines significantly.

The UI is functional but widely considered less retail-polished than cTrader, TradeLocker, or Match-Trader. For brokers whose acquisition strategy depends on client-facing platform appeal, this matters.

The SKU proliferation (XT vs CFD vs FX variants) creates internal evaluation confusion - prospects frequently need a second conversation just to identify the right product. An operator doing an RFP should specifically ask: which SKU is recommended for our asset list, what is in-scope vs out-of-scope per SKU, and what is the cost delta. Expect the vendor to resist a clean side-by-side comparison.

Startup brokers on tight timelines should also note that while a 7-day off-the-shelf deployment is advertised, any meaningful customization for a CySEC-regulated environment (branded reporting, MAM, IB tooling) will push that timeline substantially. The gap between the headline claim and the practical go-live for a regulated broker is not adequately surfaced in standard vendor materials.

Update 2026-06-09: Ecosystem expansion 2026 H1: integrated with Arizet PropTech (CRM + risk + payouts + compliance for prop firms), B2BROKER B2CORE CRM, Advanced Markets liquidity, Finalto liquidity, and DDXpro plugin. DXtrade is now the most-integrated non-MetaTrader platform in the 2026 prop firm + broker ecosystem.

Source: https://www.financemagnates.com/forex/products/dxtrade-links-prop-firms-to-arizets-real-time-risk-platform/